Albert Bourla
The Latest
-
Pfizer CEO Says Company Can Counter Vaccine-Resistant Variant Within 3 Months
But a virologist says the possibility of a vaccine-resistant variant was unlikely. 
But a virologist says the possibility of a vaccine-resistant variant was unlikely. -
Pfizer CEO Sells $5.6 Million In Stock Following Vaccine Success
The share sale is above board, the SEC says because it was approved in August. 
The share sale is above board, the SEC says because it was approved in August.
